166 related articles for article (PubMed ID: 10785541)
1. Cannabimimetic fatty acid derivatives in cancer and inflammation.
Di Marzo V; Melck D; De Petrocellis L; Bisogno T
Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):43-61. PubMed ID: 10785541
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
3. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
4. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
[TBL] [Abstract][Full Text] [Related]
5. Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2H3 basophilic leukaemic cells.
Granberg M; Fowler CJ; Jacobsson SO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):66-73. PubMed ID: 11485041
[TBL] [Abstract][Full Text] [Related]
6. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
7. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
8. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
[TBL] [Abstract][Full Text] [Related]
9. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
Fowler CJ; Jacobsson SO
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):193-200. PubMed ID: 12052035
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.
Franklin A; Parmentier-Batteur S; Walter L; Greenberg DA; Stella N
J Neurosci; 2003 Aug; 23(21):7767-75. PubMed ID: 12944505
[TBL] [Abstract][Full Text] [Related]
11. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
Di Marzo V; Bisogno T; Sugiura T; Melck D; De Petrocellis L
Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
Fowler CJ; Jonsson KO; Tiger G
Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
[TBL] [Abstract][Full Text] [Related]
13. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
14. Finding of endocannabinoids in human eye tissues: implications for glaucoma.
Chen J; Matias I; Dinh T; Lu T; Venezia S; Nieves A; Woodward DF; Di Marzo V
Biochem Biophys Res Commun; 2005 May; 330(4):1062-7. PubMed ID: 15823551
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes.
Bisogno T; Maurelli S; Melck D; De Petrocellis L; Di Marzo V
J Biol Chem; 1997 Feb; 272(6):3315-23. PubMed ID: 9013571
[TBL] [Abstract][Full Text] [Related]
16. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
Lau AH; Chow SS
Eur J Pharmacol; 2003 Mar; 464(2-3):229-35. PubMed ID: 12620517
[TBL] [Abstract][Full Text] [Related]
17. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors.
De Petrocellis L; Davis JB; Di Marzo V
FEBS Lett; 2001 Oct; 506(3):253-6. PubMed ID: 11602256
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity.
Petrosino S; Schiano Moriello A; Verde R; Allarà M; Imperatore R; Ligresti A; Mahmoud AM; Peritore AF; Iannotti FA; Di Marzo V
J Neuroinflammation; 2019 Dec; 16(1):274. PubMed ID: 31878942
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
Farquhar-Smith WP; Jaggar SI; Rice AS
Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
